Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up.

Muñoz X, Álvarez-Puebla MJ, Arismendi E, Arochena L, Ausín MDP, Barranco P, Bobolea I, Cañas JA, Cardaba B, Crespo A, Del Pozo V, Domínguez-Ortega J, Fernandez-Nieto MDM, Giner J, González-Barcala FJ, Luna JA, Mullol J, Ojanguren I, Olaguibel JM, Picado C, Plaza V, Quirce S, Ramos D, Rial M, Romero-Mesones C, Salgado FJ, San-José ME, Sánchez-Diez S, Sastre B, Sastre J, Soto L, Torrejón M, Urnadoz M, Valdes L, Valero A, Cruz MJ.

Arch Bronconeumol. 2018 Mar 19. pii: S0300-2896(18)30009-7. doi: 10.1016/j.arbres.2017.12.012. [Epub ahead of print] English, Spanish.

2.

Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.

Suarez-Cuartin G, Giner J, Merino JL, Rodrigo-Troyano A, Feliu A, Perea L, Sanchez-Reus F, Castillo D, Plaza V, Chalmers JD, Sibila O.

Respir Med. 2018 Mar;136:111-117. doi: 10.1016/j.rmed.2018.02.008. Epub 2018 Feb 13.

PMID:
29501241
3.

Learning and Recall of Medical Treatment-Related Information in Older Adults Using the Differential Outcomes Procedure.

Plaza V, Molina M, Fuentes LJ, Estévez AF.

Front Psychol. 2018 Feb 14;9:157. doi: 10.3389/fpsyg.2018.00157. eCollection 2018.

4.

Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.

de Llano LP, Cosío BG, Iglesias A, de Las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, Torrego A, Martinez-Moragon E, Soriano JB, Viña AL, Bobolea I.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 12;13:591-601. doi: 10.2147/COPD.S153694. eCollection 2018.

5.

Anxiety, Depression, and Asthma Control: Changes After Standardized Treatment.

Sastre J, Crespo A, Fernandez-Sanchez A, Rial M, Plaza V; investigators of the CONCORD Study Group.

J Allergy Clin Immunol Pract. 2018 Feb 15. pii: S2213-2198(18)30094-1. doi: 10.1016/j.jaip.2018.02.002. [Epub ahead of print]

PMID:
29454162
6.

Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.

Martínez-Rivera C, Crespo A, Pinedo-Sierra C, García-Rivero JL, Pallarés-Sanmartín A, Marina-Malanda N, Pascual-Erquicia S, Padilla A, Mayoralas-Alises S, Plaza V, López-Viña A, Picado C.

Respir Med. 2018 Feb;135:22-28. doi: 10.1016/j.rmed.2017.12.013. Epub 2018 Jan 3.

PMID:
29414449
7.

Errors in the Use of Inhalers by Health Care Professionals: A Systematic Review.

Plaza V, Giner J, Rodrigo GJ, Dolovich MB, Sanchis J.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):987-995. doi: 10.1016/j.jaip.2017.12.032. Epub 2018 Jan 31.

PMID:
29355645
8.

The Role of FENO in the Diagnosis and Control of Asthma. Expert Multidisciplinary Group Debate during the Asthma Meeting Point 2017.

Plaza V, Cosio BG, Entrenas LM, Olaguíbel JM, Pérez de Llano L, Quirce S; miembros del Grupo Multidisciplinar del Asma Meeting Point (AMP) 2017.

Arch Bronconeumol. 2018 Apr;54(4):237-238. doi: 10.1016/j.arbres.2017.09.016. Epub 2017 Dec 20. English, Spanish. No abstract available.

9.

Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.

Pérez de Llano L, Cosío BG, Miravitlles M, Plaza V; CHACOS study group.

Arch Bronconeumol. 2018 Apr;54(4):198-204. doi: 10.1016/j.arbres.2017.10.007. Epub 2017 Dec 9. English, Spanish.

10.

Update on questionnaires for assessing adherence to inhaler devices in respiratory patients.

Plaza V.

Curr Opin Allergy Clin Immunol. 2018 Feb;18(1):44-50. doi: 10.1097/ACI.0000000000000410. Review.

PMID:
29135485
11.

Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood.

Crespo-Lessmann A, Mateus E, Torrejón M, Belda A, Giner J, Vidal S, Sibila O, Plaza V.

J Asthma Allergy. 2017 Oct 12;10:269-276. doi: 10.2147/JAA.S142200. eCollection 2017.

12.

Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate-severe asthma.

Crespo-Lessmann A, Plaza V, González-Barcala FJ, Fernández-Sánchez T, Sastre J.

BMJ Open Respir Res. 2017 Sep 13;4(1):e000189. doi: 10.1136/bmjresp-2017-000189. eCollection 2017.

13.

[Is the introduction of clinical management programs for patients with chronic obstructive pulmonary disease useful? Comparison of the effectiveness of two interventions on the clinical progress and care received].

Solanes I, Bolíbar I, Llauger MA, Peiro M, Valverde P, Fraga M, Medrano C, Bigorra T, Freixas M, Ligüerre I, Pou MA, Domínguez L, Valero C, Solà J, Giner J, Plaza V; el grupo de estudio del Proceso EPOC.

Aten Primaria. 2018 Mar;50(3):184-196. doi: 10.1016/j.aprim.2017.01.014. Epub 2017 Jul 21. Spanish.

14.

Multidisciplinary Consensus on the Nonadherence to Clinical Management of Inhaled Therapy in Spanish asthma patients.

López-Viña A, Giner J, Molina J, Palicio J, Plaza J, Quintano JA, Quirce S, Soria C, Uréndez AM, Plaza V.

Clin Ther. 2017 Aug;39(8):1730-1745.e1. doi: 10.1016/j.clinthera.2017.06.010. Epub 2017 Jul 12.

PMID:
28709688
15.

Fibromyalgia as a cause of uncontrolled asthma: a case-control multicenter study.

Martinez-Moragon E, Plaza V, Torres I, Rosado A, Urrutia I, Casas X, Hinojosa B, Blanco-Aparicio M, Delgado J, Quirce S, Sabadell C, Cebollero P, Muñoz-Fernández A.

Curr Med Res Opin. 2017 Dec;33(12):2181-2186. doi: 10.1080/03007995.2017.1354828. Epub 2017 Aug 11.

PMID:
28699806
16.

Impact of Asthma on the Sexual Functioning of Patients. A Case-Control Study.

Soto Campos JG, Rojas Villegas J, Padilla Galo A, Marina Malanda N, Garcia Rivero JL, Pinedo Sierra C, Garcia Salmones M, Cabrera Galán C, Segura Molina E, Plaza V, Pascual Erquicia S; Grupo Emergente de Asma (GEA) del Área de Asma de la SEPAR.

Arch Bronconeumol. 2017 Dec;53(12):667-674. doi: 10.1016/j.arbres.2017.05.011. Epub 2017 Jun 21. English, Spanish.

17.

Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.

Suarez-Cuartin G, Smith A, Abo-Leyah H, Rodrigo-Troyano A, Perea L, Vidal S, Plaza V, Fardon TC, Sibila O, Chalmers JD.

Respir Med. 2017 Jul;128:1-6. doi: 10.1016/j.rmed.2017.05.001. Epub 2017 May 2.

PMID:
28610665
18.

Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA).

Plaza V, Álvarez F, Calle M, Casanova C, Cosío BG, López-Viña A, Pérez de Llano L, Quirce S, Román-Rodríguez M, Soler-Cataluña JJ, Miravitlles M.

Arch Bronconeumol. 2017 Aug;53(8):443-449. doi: 10.1016/j.arbres.2017.04.002. Epub 2017 May 8. English, Spanish.

19.

Motivational interviewing for adherence: post-training attitudes and perceptions of physicians who treat asthma patients.

Román-Rodríguez M, Ibarrola-Ruiz L, Mora F, Plaza V, Sastre J, Torrego A, Vega JM, Sánchez-Herrero G.

Patient Prefer Adherence. 2017 Apr 21;11:811-820. doi: 10.2147/PPA.S127645. eCollection 2017.

20.

Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.

Miravitlles M, Alvarez-Gutierrez FJ, Calle M, Casanova C, Cosio BG, López-Viña A, Pérez de Llano L, Quirce S, Roman-Rodríguez M, Soler-Cataluña JJ, Plaza V.

Eur Respir J. 2017 May 1;49(5). pii: 1700068. doi: 10.1183/13993003.00068-2017. Print 2017 May. No abstract available.

PMID:
28461301
21.

Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?

Cosío BG, Pérez de Llano L, Lopez Viña A, Torrego A, Lopez-Campos JL, Soriano JB, Martinez Moragon E, Izquierdo JL, Bobolea I, Callejas J, Plaza V, Miravitlles M, Soler-Catalunya JJ; on behalf of the CHACOS study group.

Eur Respir J. 2017 May 1;49(5). pii: 1602397. doi: 10.1183/13993003.02397-2016. Print 2017 May.

PMID:
28461299
22.

Quality Indicators of Asthma Care Derived From the Spanish Guidelines for Asthma Management (GEMA 4.0): A Multidisciplinary Team Report.

Quirce S, Delgado J, Entrenas LM, Grande M, Llorente C, López Viña A, Martínez Moragón E, Mascarós E, Molina J, Olaguibel JM, Pérez de Llano LA, Perpiñá Tordera M, Quintano JA, Rodríguez M, Román-Rodriguez M, Sastre J, Trigueros JA, Valero AL, Zoni AC, Plaza V; ASMAFORUM II Group.

J Investig Allergol Clin Immunol. 2017;27(1):69-73. doi: 10.18176/jiaci.0121. No abstract available.

23.

Multidisciplinary expert discussion. Uncontrolled asthma: causes, consequences and possible solutions

Plaza V, Quirce S, Delgado J, Martinez Moragón E, Pérez de Llano L; Grupo multidisciplinar de expertos "Asmaforum".

An Sist Sanit Navar. 2016 Nov 21;39(3):357-370. doi: 10.23938/ASSN.0233. Spanish.

24.

Near-fatal asthma: a heterogeneous clinical entity.

Serrano-Pariente J, Plaza V.

Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):28-35. doi: 10.1097/ACI.0000000000000333. Review.

PMID:
27870665
25.

Asthma-chronic obstructive pulmonary disease overlap syndrome: a controversial concept.

Rodrigo GJ, Neffen H, Plaza V.

Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):36-41. doi: 10.1097/ACI.0000000000000326. Review.

PMID:
27841767
26.

Asthma outcomes improve with continuous positive airway pressure for obstructive sleep apnea.

Serrano-Pariente J, Plaza V, Soriano JB, Mayos M, López-Viña A, Picado C, Vigil L; CPASMA Trial Group.

Allergy. 2017 May;72(5):802-812. doi: 10.1111/all.13070. Epub 2016 Nov 3.

27.

Test of Adherence to Inhalers.

Plaza V, López-Viña A, Cosio BG; en representación del Comité Científico del Proyecto TAI.

Arch Bronconeumol. 2017 Jul;53(7):360-361. doi: 10.1016/j.arbres.2016.08.006. Epub 2016 Oct 15. English, Spanish. No abstract available.

28.

[Identification of gaps in the clinical patient care of asthma in Spain. Results of the OPTIMA-GEMA survey].

Plaza V, Rodríguez del Río P, Gómez F, López Viña A, Molina J, Quintano JA, Quirce S, Soler R, Villa JR, Nieto A.

An Sist Sanit Navar. 2016 Mayo-Agosto;39(2):181-201. doi: 10.23938/ASSN.0274. Spanish.

29.

Recent Advances in the Study of the Plant Pathogenic Fungus Botrytis cinerea and its Interaction with the Environment.

Castillo L, Plaza V, Larrondo LF, Canessa P.

Curr Protein Pept Sci. 2017;18(10):976-989. doi: 10.2174/1389203717666160809160915. Review.

PMID:
27526927
30.

Attitudes and barriers uncontrolled asthma in Spain. Abanico study.

Martinez-Moragon E, Entrenas LM, Plaza V, Quirce S.

Rev Clin Esp. 2017 Jan - Feb;217(1):60-62. doi: 10.1016/j.rce.2016.06.008. Epub 2016 Jul 30. English, Spanish. No abstract available.

PMID:
27484344
31.

Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD.

Rodrigo-Troyano A, Suarez-Cuartin G, Peiró M, Barril S, Castillo D, Sanchez-Reus F, Plaza V, Restrepo MI, Chalmers JD, Sibila O.

Respirology. 2016 Oct;21(7):1235-42. doi: 10.1111/resp.12825. Epub 2016 Jun 20.

PMID:
27325555
32.

Once-daily fluticasone furoate and vilanterol for adolescents and adults with symptomatic asthma: A systematic review with meta-analysis.

Rodrigo GJ, Plaza V.

Ann Allergy Asthma Immunol. 2016 Jun;116(6):565-70. doi: 10.1016/j.anai.2016.03.035. Epub 2016 Apr 23. Review.

PMID:
27117053
33.

Expression of toll-like receptors 2 and 4 in subjects with asthma by total serum IgE level.

Crespo-Lessmann A, Mateus E, Vidal S, Ramos-Barbón D, Torrejón M, Giner J, Soto L, Juárez C, Plaza V.

Respir Res. 2016 Apr 16;17:41. doi: 10.1186/s12931-016-0355-2.

34.

The Differential Outcomes Procedure Enhances Adherence to Treatment: A Simulated Study with Healthy Adults.

Molina M, Plaza V, Fuentes LJ, Estévez AF.

Front Psychol. 2015 Nov 20;6:1780. doi: 10.3389/fpsyg.2015.01780. eCollection 2015.

35.

Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.

Sibila O, Garcia-Bellmunt L, Giner J, Rodrigo-Troyano A, Suarez-Cuartin G, Torrego A, Castillo D, Solanes I, Mateus EF, Vidal S, Sanchez-Reus F, Sala E, Cosio BG, Restrepo MI, Anzueto A, Chalmers JD, Plaza V.

Ann Am Thorac Soc. 2016 May;13(5):636-42. doi: 10.1513/AnnalsATS.201512-797OC.

PMID:
26882402
36.

Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer.

Plaza V, Crespo A, Giner J, Merino JL, Ramos-Barbón D, Mateus EF, Torrego A, Cosio BG, Agustí A, Sibila O.

J Investig Allergol Clin Immunol. 2015;25(6):431-7.

37.

Differences in Adherence and Non-Adherence Behaviour Patterns to Inhaler Devices Between COPD and Asthma Patients.

Plaza V, López-Viña A, Entrenas LM, Fernández-Rodríguez C, Melero C, Pérez-Llano L, Gutiérrez-Pereyra F, Tarragona E, Palomino R, Cosio BG.

COPD. 2016 Oct;13(5):547-54. doi: 10.3109/15412555.2015.1118449. Epub 2016 Jan 20.

PMID:
26788620
38.

Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum.

Crespo A, Giner J, Torrejón M, Belda A, Mateus E, Granel C, Torrego A, Ramos-Barbón D, Plaza V.

J Asthma. 2016 Jun;53(5):459-64. doi: 10.3109/02770903.2015.1116086. Epub 2016 Jan 19.

PMID:
26785727
39.

Utility of Induced Sputum in Routine Clinical Practice.

Barril S, Sebastián L, Cotta G, Crespo A, Mateus E, Torrejón M, Ramos-Barbón D, Plaza V.

Arch Bronconeumol. 2016 May;52(5):250-5. doi: 10.1016/j.arbres.2015.10.002. Epub 2015 Dec 3. English, Spanish.

40.

A repeated short educational intervention improves asthma control and quality of life.

Plaza V, Peiró M, Torrejón M, Fletcher M, López-Viña A, Ignacio JM, Quintano JA, Bardagí S, Gich I; PROMETHEUS Study Group.

Eur Respir J. 2015 Nov;46(5):1298-307. doi: 10.1183/13993003.00458-2015. Epub 2015 Sep 24.

41.

What pulmonologists think about the asthma-COPD overlap syndrome.

Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 15;10:1321-30. doi: 10.2147/COPD.S88667. eCollection 2015.

42.

Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients.

Plaza V, Fernández-Rodríguez C, Melero C, Cosío BG, Entrenas LM, de Llano LP, Gutiérrez-Pereyra F, Tarragona E, Palomino R, López-Viña A; TAI Study Group.

J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):142-52. doi: 10.1089/jamp.2015.1212. Epub 2015 Jul 31.

43.

Knowledge and Attitudes of Nurses in Spain about Inhaled Therapy: Results of a National Survey.

Giner J, Roura P, Hernández C, Torrejón M, Peiró M, Fernández MJ, López de Santa María E, Gimeno MA, Macian V, Tarragona E, Plaza V.

J Aerosol Med Pulm Drug Deliv. 2015 Jul 13. [Epub ahead of print]

PMID:
26168021
44.

Usefulness of the Exhaled Breath Temperature Plateau in Asthma Patients.

Crespo Lessmann A, Giner J, Torrego A, Mateus E, Torrejón M, Belda A, Plaza V.

Respiration. 2015;90(2):111-7. doi: 10.1159/000431259. Epub 2015 Jun 20.

45.

Identification and characterization of near-fatal asthma phenotypes by cluster analysis.

Serrano-Pariente J, Rodrigo G, Fiz JA, Crespo A, Plaza V; High Risk Asthma Research Group.

Allergy. 2015 Sep;70(9):1139-47. doi: 10.1111/all.12654. Epub 2015 Jun 9.

PMID:
26011771
46.

Variability in Asthma Inflammatory Phenotype in Induced Sputum. Frequency and Causes.

Suárez-Cuartín G, Crespo A, Mateus E, Torrejón M, Giner J, Belda A, Ramos-Barbón D, Torrego A, Plaza V.

Arch Bronconeumol. 2016 Feb;52(2):76-81. doi: 10.1016/j.arbres.2015.03.007. Epub 2015 May 4. English, Spanish.

47.

bcpmr1 encodes a P-type Ca(2+)/Mn(2+)-ATPase mediating cell-wall integrity and virulence in the phytopathogen Botrytis cinerea.

Plaza V, Lagües Y, Carvajal M, Pérez-García LA, Mora-Montes HM, Canessa P, Larrondo LF, Castillo L.

Fungal Genet Biol. 2015 Mar;76:36-46. doi: 10.1016/j.fgb.2015.01.012. Epub 2015 Feb 9.

PMID:
25677379
48.

Assessment of the internal structure of GOLD 2011 system.

Rodrigo GJ, Soler-Cataluña JJ, Solanes I, Bolibar I, Llauger MA, Plaza V.

Pulm Pharmacol Ther. 2015 Feb;30:87-92. doi: 10.1016/j.pupt.2014.12.002. Epub 2014 Dec 27.

PMID:
25549570
49.

Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014.

Agustí A, Antó JM, Auffray C, Barbé F, Barreiro E, Dorca J, Escarrabill J, Faner R, Furlong LI, Garcia-Aymerich J, Gea J, Lindmark B, Monsó E, Plaza V, Puhan MA, Roca J, Ruiz-Manzano J, Sampietro-Colom L, Sanz F, Serrano L, Sharpe J, Sibila O, Silverman EK, Sterk PJ, Sznajder JI.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):391-401. doi: 10.1164/rccm.201410-1935PP.

50.

Sustainability and power in health promotion: community-based participatory research in a reproductive health policy case study in New Mexico.

Mendes R, Plaza V, Wallerstein N.

Glob Health Promot. 2016 Mar;23(1):61-74. doi: 10.1177/1757975914550255. Epub 2014 Nov 28.

PMID:
25432963

Supplemental Content

Support Center